Nosocomial Pneumonia Associated to PVL-Producing Staphylococcus aureus in Children in Benin

Table 1

Clinical data of the 10 young infants concerned by pneumonia due to S. aureus.

Patient age	Pathology at admission	Time delay (days) before pneumonia	C reactive protein	Pulsotype	S. aureus Toxin associated	Evolution after treatment
No. 1—8 mo.	Malaria marasmus	15	96	AI, A1, 2	TSST-1	Fatal 4 days
No. 2—9 mo.	Malaria, Severe anaemia	18	192	AII, A3, 4, 6	PVL	Fatal 15 days
No. 3—24 mo.	Typhoid fever, Malnutrition	23	96	AII, A3, 4, 6	PVL	Fatal 3 days
No. 4—10 mo.	Severe malaria; Crisis	11	192	AII, A3, 4, 6	PVL	Fatal 7 days
No. 5—9 mo.	Severe malaria	15	96	AII, A3, 4, 6	PVL	Fatal 2 days
No. 6—3 mo.	Typhoid fever	18	96	AII, A3, 4, 6	PVL	Fatal 4 days
No. 7—5 mo.	severe malaria	15	192	AII, A3, 4, 6	PVL	Fatal 7 days
No. 8—7 mo.	Malaria and; Anaemia	18	288	AIII	PVL	Fatal 20 hours
No. 9—7 y.o.	Malaria and; Malnutrition	7	192	AII, A3, 4, 6	PVL	Rescue after blood transfusion, leaving hospital at day 31,; skin lesions
No. 10—11 mo.	Severe malaria	16	192	AII, A3, 4, 6		Fatal 5 days